EMVision Medical Devices Ltd
EMVision Medical Devices Ltd
Your view on EMV.AX
Overview
What the company does, where it operates, and who runs it.
About EMVision Medical Devices Ltd
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Scott Philip Kirkland
- Headquarters
- 65 Epping Road, Macquarie Park, NSW, AU
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Scott Philip Kirkland
- Headquarters
- 65 Epping Road, Macquarie Park, NSW, AU
EMVision Medical Devices Limited is an Australian enterprise specializing in the innovation, development, and market introduction of advanced imaging and diagnostic healthcare technologies.
The company's principal offering is a compact, mobile brain scanner engineered for the swift detection and continuous tracking of strokes, in addition to fulfilling other medical imaging necessities. Founded in 2017, its operations are headquartered in Macquarie Park.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for EMVision Medical Devices Ltd. Starting points for EMVision Medical Devices Ltd: EPS -AUD 0.09, beta 1.06 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for EMVision Medical Devices Ltd. EMVision Medical Devices Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for EMVision Medical Devices Ltd. Trailing twelve-month EPS for EMVision Medical Devices Ltd stands at -AUD 0.09. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|
| Average estimate | −AUD 0.15 | −AUD 0.16 |
| Lowest estimate | −AUD 0.15 | −AUD 0.16 |
| Highest estimate | −AUD 0.15 | −AUD 0.16 |
| Number of analysts | 1 | 1 |
| A year ago | −AUD 0.09 | — |
| Growth vs a year ago | −67.6% | — |
Revenue estimates
| Total | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|
| Average estimate | AUD 5.00M | AUD 5.60M |
| Lowest estimate | AUD 5.00M | AUD 5.60M |
| Highest estimate | AUD 5.00M | AUD 5.60M |
| Number of analysts | 1 | 1 |
| A year ago | AUD 0.00 | — |
| Growth vs a year ago | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for EMVision Medical Devices Ltd. EMVision Medical Devices Ltd has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| 4DX.AX4DMedical Limited | Healthcare | Medical - Devices | — | ||
| CMP.AXCompumedics Limited | Healthcare | Medical - Devices | — | ||
| EBR.AXEBR Systems, Inc. | Healthcare | Medical - Devices | — | ||
| EYE.AXNova Eye Medical Limited | Healthcare | Medical - Devices | — | ||
| HMD.AXHeraMED Limited | Healthcare | Medical - Devices | — | ||
| IMR.AXImricor Medical Systems, Inc. | Healthcare | Medical - Specialties | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| BVSBioventus Inc. | Healthcare | NASDAQ | $727.2M | ||
| CALZFPolyNovo Limited | Healthcare | OTC | $472.9M | ||
| CARLCARLSMED, INC. | Healthcare | NASDAQ | $476.0M | ||
| CATXPerspective Therapeutics, Inc. | Healthcare | AMEX | $94.2M | ||
| CBL.AXControl Bionics Limited | Healthcare | ASX | — | ||
| CBLLCeriBell, Inc. | Healthcare | NASDAQ | $995.3M | ||
| CERSCerus Corporation | Healthcare | NASDAQ | $391.8M | ||
| CGHCCapital Group Holdings, Inc. | Healthcare | OTC | $9,220 | ||
| CHEOFCochlear Limited | Healthcare | OTC | $8.9B | ||
| CHEOYCochlear Limited | Healthcare | OTC | $9.2B | ||
| CHYPFHealth Logic Interactive Inc. | Healthcare | OTC | $165,839 | ||
| CLLKFBICO Group AB (publ) | Healthcare | OTC | $123.3M | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of EMVision Medical Devices Ltd.